Characterization of carbapenem-resistant Gram-negative bacteria from Tamil Nadu

Journal of Chemotherapy

Volumn 28, Issue 5, 2016, Pages 371-374

  Nachimuthu, Ramesh ^a   Subramani, Ramkumar ^b   Maray, Suresh ^c   Gothandam, K M ^a   Sivamangala, Karthikeyan ^a   Manohar, Prasanth ^a   Bozdogan, Bülent ^a,d  

^a VIT UNIVERSITY   (India)

^b Hi Tech Diagnostic Centre   (India)

^c MAJMAAH UNIVERSITY   (Saudi Arabia)

^d ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Carbapenem resistance; ERIC PCR; Gram negative bacteria; Meropenem; NDM; OXA

Indexed keywords

CARBAPENEM; MEROPENEM; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ARTICLE; BACTERIAL GROWTH; CENTRIFUGATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISK DIFFUSION; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HUMAN; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; GENETICS; GRAM NEGATIVE INFECTION; INDIA; MICROBIAL SENSITIVITY TEST;

BETA-LACTAMASES; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS;

EID: 84979561762     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/1973947815Y.0000000056     Document Type: Article

References (17)

1. K.M.Papp-Wallace, A.Endimiani, M.A.Taracila, R.A.Bonomo. Carbapenems:past, present, and future. Antimicrob Agents Chemother. 2011;55(11):4943–60.
2. A.P.Zavascki, C.G.Carvalhaes, R.C.Picao, A.C.Gales. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii:resistance mechanisms and implications for therapy. Expert Rev Anti Infect Ther. 2010;8(1):71–93.
3. A.E.Clatworthy, E.Pierson, D.T.Hung. Targeting virulence:a new paradigm for antimicrobial therapy. Nat Chem. 2007;3(9):541–8.
4. R.Canton, M.Akova, Y.Carmeli, C.G.Giske, Y.Glupczynski, M.Gniadkowski, Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect. 2012;18(5):413–31.
5. R.C.MoelleringJr. NDM-1–a cause for worldwide concern. N Engl J Med. 2010;363(25):2377–9.
6. L.S.Tzouvelekis, A.Markogiannakis, M.Psichogiou, P.T.Tassios, G.L.Daikos. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae:an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25(4):682–707.
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A10. Wayne, PA:CLSI; 2009.
8. D.Doyle, G.Peirano, C.Lascols, T.Lloyd, D.L.Church, J.D.Pitout. Laboratory detection of Enterobacteriaceae that produce carbapenemases. J Clin Microbiol. 2012;50(12):3877–80.
9. J.Versalovic, M.Schneid, F.J.de Bruijn, J.R.Lupski. Genomic fingerprinting of bacteria using repetitive sequence-based polymerase chain reaction. Methods Mol Cell Biol. 1994;5:25–40.
10. NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53:5046–54.
11. K.K.Kumarasamy, M.A.Toleman, T.R.Walsh, J.Bagaria, F.Butt, R.Balakrishnan. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK:a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10:597–602.
12. NDM-1 positive Providencia rettgeri in Israel. J Clin Microbiol. 2013;14:1642–3.
13. A.P.Carvalho-Assef, P.S.Pereira, R.M.Albano, G.C.Beriao, T.P.Chagas, L.N.Timm, Isolation of NDM-producing Providencia rettgeri in Brazil. J Antimicrob Chemother. 2013;68(12):2956–7.
14. G.Zhou, S.Guo, Y.Luo, L.Ye, Y.Song, G.Sun, NDM-1–producing strains, family Enterobacteriaceae, in hospital, Beijing, China. Emerg Infect Dis. 2014;20(2):340–2.
15. L.Dortet, L.Poirel, P.Nordmann. Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria. Biomed Res Int. 2014;2014:249856.
16. M.Castanheira, L.M.Deshpande, D.Mathai, J.M.Bell, R.N.Jones, R.E.Mendes. Early dissemination of NDM-1 and OXA-181 producing Enterobacteriaceae in Indian hospitals:report from the SENTRY antimicrobial surveillance program, 2006–2007. Antimicrob Agents Chemother. 2011;55:1274–8.
17. S.Y.Saavedra, C.Duarte, M.N.Gonzalez, M.E.Realpe. Characterization of isolates of carbapenemase-producing Pseudomonas aeruginosa from seven Colombian provinces. Biomedica. 2014;34(Suppl 1):217–23.